Supreme Court Ruling on Mifepristone Telehealth Access Upends Abortion Medication Landscape The Supreme Court's recent decision has sent shockwaves through the reproductive rights community.
The ruling effectively overturns the FDA's COVID 19 era policy allowing mifepristone to be prescribed remotely, instead requiring patients to obtain the medication in person from a registered healthcare provider.
Mifepristone is a crucial component of medical abortions, working by blocking progesterone receptors and preventing implantation or terminating an existing pregnancy.